Alector, Inc.

Stocks

Market Closed - Nasdaq 06:00:00 04/09/26 am AEST			5-day change	1st Jan Change
2.510 ^USD	-7.72%		+5.02%	+60.90%

07/08	Alector, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
09/07	Wall Street Ignores the Sirens

Published on 09/23/2025 at 04:50 am AEST - Modified on 09/23/2025 at 11:05 am AEST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good morning, ladies and gentlemen, and welcome to Alector's conference call and webcast highlighting its progranulin franchise and Alector Brain

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

07/08	Alector, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
09/07	Wall Street Ignores the Sirens
09/07	GSK adds Royal Philips' Chief Executive Jakobs to board	AN
09/07	Oil keeps markets on edge
09/07	UK Stocks-Factors to watch on July 9	RE
09/07	Alector and GSK partnership to end after dementia, Alzheimer's drug failures	RE
09/07	Alector, Inc. Announces Termination of Collaboration Agreement with Glaxo Wellcome UK Limited	CI
09/07	Alector LLC and Alector, Inc. Repay $10,428,827.77 Aggregate Principal Amount Of Loans Under Loan And Security Agreement With Hercules Capital, Inc	CI
08/05	Alector, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
06/05	Alector, Inc. - Special Call
30/04	Alector to discontinue phase 2 trial of nivisnebart	RE
30/04	Alector Inc Discontinues Phase 2 Progress-Ad Trial of Nivisnebart and Provides Pipeline Update	CI
16/04	Alector Shares Rise After Cantor Fitzgerald Upgrade	MT
15/04	Cantor Fitzgerald Upgrades Alector to Overweight From Neutral	MT
13/03	Alector Files $400 Million Mixed Shelf	MT

Duration

Period

Sector